Atlas Trials

PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma

Clinical trial NCT07128290 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07128290
Sponsor
Federation Francophone de Cancerologie Digestive
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Intrahepatic Cholangiocarcinoma (Icc)
Start date
2025-10-30
Primary completion
2029-04-30
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.